SCHEMBL22340915

SCHEMBL22340915

CCCCCCCCN(Cc1ccc(OC)cc1)C1CCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.48
CNR2 P34972 3/20 0.45
CNR1 P21554 1/20 0.44
USP2 O75604 2/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 3/20 0.43
APAF1 O14727 1/20 0.43
NR1I2 O75469 1/20 0.43
HSP90AA1 P07900 1/20 0.43
IDE P14735 1/20 0.43
UBE2N P61088 1/20 0.43
MEN1 O00255 2/20 0.41
DRD3 P35462 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22340459 1.00 DRD2 (0.48) DRD2CNR2CNR1USP2LMNA
SCHEMBL22340438 1.00 DRD2 (0.48) DRD2CNR2CNR1USP2LMNA
SCHEMBL29334852 1.00 DRD2 (0.48) DRD2CNR2CNR1USP2LMNA
SCHEMBL22340723 1.00 DRD2 (0.48) DRD2CNR2CNR1USP2LMNA
SCHEMBL20870807 0.99 DRD2 (0.47) DRD2CNR2CNR1USP2LMNA
SCHEMBL20871142 0.99 DRD2 (0.49) DRD2CNR2CNR1USP2LMNA
SCHEMBL20871388 0.94 DRD2 (0.50) DRD2CNR2CNR1USP2LMNA
SCHEMBL29336126 0.89 DRD2 (0.58) DRD2CNR2CNR1KMT2AMEN1
SCHEMBL20871846 0.83 CNR1 (0.52) DRD2CNR2CNR1LMNATSHR
SCHEMBL5993873 0.83 SLC6A2 (0.57) DRD2KMT2ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3707132-B1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES UNIV PARIS SACLAY (FR) 2024-07-17 EP disclosed
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines Universite Paris-Saclay (FR) 2021-06-15 US disclosed
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES Universite Paris-Saclay (FR) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES ADH1C, ADH1A, ADH5 DRD2 58/4885CNR2 1633/4885CNR1 1297/4885
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines ADH1C, PNMT, ADH1A DRD2 91/4885CNR2 2182/4885CNR1 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.